Fatal acetaminophen poisoning with hepatic microvesicular steatosis in a child after repeated administration of therapeutic doses.


Journal

Forensic science international
ISSN: 1872-6283
Titre abrégé: Forensic Sci Int
Pays: Ireland
ID NLM: 7902034

Informations de publication

Date de publication:
May 2020
Historique:
received: 16 12 2019
accepted: 12 03 2020
pubmed: 2 4 2020
medline: 4 11 2020
entrez: 2 4 2020
Statut: ppublish

Résumé

Acetaminophen is the leading cause of acute liver failure worldwide following massive ingestion. We present here a fatal acute liver failure after repeated administration of four therapeutic doses of acetaminophen at 4-h intervals in a previously healthy 9-year-old female who presented dental pain after a facial trauma during sport practice. A diagnosis of paracetamol-induced hepatitis was deduced from the clinical picture of fulminant hepatitis and tubular necrosis, the encephalopathy with oedema and without signs of trauma. Liver biopsy showed typical acetaminophen-induced necrosis and a microvesicular steatosis in periportal hepatocytes. These injuries might have been favored by pre-existing mitochondrial dysfunction related, for instance, to a deficiency in an enzyme of the mitochondrial β-oxidation pathway, or the respiratory chain. The observation of microvesicular steatosis in the periportal areas suggests an increased vulnerability via pre-existing mitochondrial dysfunction. As the liver status of patients is mostly unknown, the frequency of administration (every six hours) must be respected and the use of pharmaceutical forms allowing to adjust the dose as closely as possible to the child's weight should be promoted.

Identifiants

pubmed: 32229318
pii: S0379-0738(20)30120-1
doi: 10.1016/j.forsciint.2020.110258
pii:
doi:

Substances chimiques

Acetaminophen 362O9ITL9D

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

110258

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There are no interest statement to declare.

Auteurs

Renaud Bouvet (R)

Department of Forensic Medicine, Rennes University Hospital, Rennes, France; IDPSP - EA 4640, Rennes University, Rennes, France.

Aurélie Cauchois (A)

Department of Forensic Medicine, Rennes University Hospital, Rennes, France; Department of Pathology, Rennes University Hospital, Rennes, France.

Alain Baert (A)

Department of Forensic Medicine, Rennes University Hospital, Rennes, France.

Bernard Fromenty (B)

Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, Rennes, France.

Isabelle Morel (I)

Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, Rennes, France; Department of Forensic Toxicology, Rennes University Hospital, Rennes, France.

Bruno Turlin (B)

Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, Rennes, France; Department of Pathology, Rennes University Hospital, Rennes, France.

Thomas Gicquel (T)

Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, Rennes, France; Department of Forensic Toxicology, Rennes University Hospital, Rennes, France. Electronic address: thomas.gicquel@chu-rennes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH